NCT03787914 is a NA clinical trial of Mobile Outreach Approach in Tuberculosis, sponsored by Ministry of Health, Saudi Arabia.

Who is sponsoring NCT03787914?

NCT03787914 is sponsored by Ministry of Health, Saudi Arabia.

What drugs are being tested in NCT03787914?

Interventions in NCT03787914: Mobile Outreach Approach.

What condition does NCT03787914 study?

NCT03787914 studies Tuberculosis.

Is NCT03787914 still recruiting?

NCT03787914 is currently completed. Last updated 27 December 2018.

Last reviewed 2018-12-27 · How we verify

NCT03787914

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Community Mobile Outreach Approach Compared to Facility Based Directly Observed Treatment Short Course on Treatment Outcome Among Tuberculosis Patients in Jeddah: A Randomized Controlled Trial

Completed NA Last updated 27 December 2018

What this trial tests

NA trial testing Mobile Outreach Approach in Tuberculosis in 200 participants. Completed in 1 November 2018.

Timeline

1 November 2017

Primary endpoint
1 November 2018

1 November 2018

Quick facts

Lead sponsor	Ministry of Health, Saudi Arabia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	200
Start date	1 November 2017
Primary completion	1 November 2018
Estimated completion	1 November 2018
Sites	1 location across Saudi Arabia

Drugs / interventions tested

Mobile Outreach Approach

Conditions studied

Tuberculosis — all drugs for Tuberculosis →

Sponsor

Ministry of Health, Saudi Arabia

Who can join

18 and older, any sex, with Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effectiveness of the community mobile outreach approach in improving treatment outcomes (success rate) among tuberculosis patients with those being treated with facility based directly observed treatment short course (DOTS) in Jeddah region.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Treatment outcomes among tuberculosis patients in Jeddah, Saudi Arabia: Results of a community mobile outreach directly observed Treatment, Short-course (DOTS) project, compared to a standard facility-based DOTS: A randomized controlled trial.
Al-Sahafi A, Al-Sayali MM, Mandoura N, Shah HBU, et al · · 2021 · cited 3× · PMID 33490640 · DOI 10.1016/j.jctube.2020.100210

Verify or expand the search:

Other recruiting trials for Tuberculosis

Currently open trials in the same condition.

NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting

Other Ministry of Health, Saudi Arabia trials

Trials by the same sponsor.

NCT06057077 — Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus · Phase 1, PHASE2 · unknown
NCT05957939 — Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial · Phase 1 · unknown
NCT06026163 — Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress · Phase 2, PHASE3 · recruiting
NCT06071338 — A Decision Support System Based on Classification Algorithms for the Diagnosis of Periodontal Disease · unknown
NCT05680662 — The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Can · EARLY_PHASE1 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03787914 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ministry of Health, Saudi Arabia
Last refreshed: 27 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03787914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing